1500006I duke university; to FY.2019.A1.0118--06 base task order funding; biod can 8470038 $126,099
Ended Awarded Last action
- Contract number
- 75N93019F00124
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $126,086
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $126,086.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$13 | |
| Original award | $126,099 |
About this award
This is a cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The potential value of the award is $126,086.19. The order was issued against the Therapeutics Against Infectious Diseases Phase 1 master contract. No set-aside designation was used. As the prime contractor, Duke University will provide clinical research and immunization safety assessment services to support the Centers for Disease Control and Prevention (CDC).
Quick answers
Who was awarded contract 75N93019F00124?
75N93019F00124 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 15, 2018.
How much is contract 75N93019F00124 worth?
The government has obligated $126,086 on 75N93019F00124.
Is contract 75N93019F00124 an order under another contract?
Yes. 75N93019F00124 is a delivery order under HHSN272201500006I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract 75N93019F00124 competed?
The extent of competition for 75N93019F00124 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award